sales staffs, advertising media fee for product promotion, distribution fee paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of company’ s products in the
Limited and its subsidiary for the first quarter ended 31 March 2018 represented a loss before the provision for doubtful accounts of Baht 3.72 million. Inclusive of the provision for doubtful accounts of
new products, our product strategies also include the shaping up additional revenue stream from distribution of diversified set of 3rd party products in both food and non-food categories. Following this
and 6-month periods ending 30 June 2017, respectively. Apart from launching new products, our product strategies also include the shaping up additional revenue stream from distribution of diversified
, respectively. Apart from launching new products, our product strategies also include the shaping up additional revenue stream from distribution of diversified set of 3rd party products in both food and non-food
period of previous year as profit of 5.26% due to revenue from selling more high tension steel and more distribution of electricity to Provincial Electricity but somehow there are some burden cost from one
brand products, and more efficient cost management. In addition, the revenue from Distribution Center was higher than cost that would affect the lower cost of inventories. 3. Selling and administrative
Expenses 12.30 30.06 13.74 2,252.46 Administrative costs (40.45) (98.85) (47.78) (7,832.79) Allowance for impairment of joint venture capital - - (29.81) (4,886.89) Doubtful accounts (90.99) (222.36) (88.24
) (8,100.00) Doubtful account (0.99) (13.16) - - Loss from impairment of investments in associate (0.01) (0.13) - - บมจ.0107537002109 Page 2 of 14 บริษทั ดีมีเตอร ์คอรป์อเรชัน่ จ ำกดั (มหำชน) Demeter
) (26.52) (5,200.00) Doubtful account (63.99) (838.66) (86.50) (16,960.78) Loss from impairment of goodwill - - (51.20) (10,039.21) Loss from impairment of investments in (0.01) (0.13) (1.64) (321.57) บมจ